p16INK4a downregulation is involved in immortalization of primary human prostate epithelial cells induced by telomerase

Molecular Carcinogenesis

Volumn 47, Issue 10, 2008, Pages 775-783

  Shao, Genze ^a   Balajee, Adayabalam S ^b   Hei, Tom K ^b   Zhao, Yongliang ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

hTERT; p16INK4a; PrEC cells

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P53; TELOMERASE; PRIMER DNA;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMOSOME; DIPLOIDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; GENE TRANSLOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; METHYLATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; CELL LINE; CYTOLOGY; DNA DAMAGE; DNA METHYLATION; EPITHELIUM CELL; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROSTATE;

ANIMALIA;

BASE SEQUENCE; CELL LINE, TRANSFORMED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA DAMAGE; DNA METHYLATION; DNA PRIMERS; DOWN-REGULATION; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROMOTER REGIONS (GENETICS); PROSTATE; TELOMERASE;

EID: 52649176515     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20434     Document Type: Article

References (43)

1. Hayflick L. Mortality and immortality at the cellular level. A review. Biochemistry 1997;62:1180-1190.
2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
3. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-352.
4. Reddel RR. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 2000;21:477-884.
5. Stewart SA, Weinberg RA. Telomerase and human tumori-genesis. Semin Cancer Biol 2000;10:399-406.
6. Shay JW, Wright WE. When do telomerers matter? Science 2001;291:839-840.
7. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91:2900-2904.
8. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
9. Maser RS, DePinho RA. Keeping telomerase in its place. Nat Med 2002;8:934-936.
10. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-791.
11. Hahn WC. Immortalization and transformation of human cells. Mol Cell 2002;13:351-361.
12. Bryan TM, Englezou A, Guptam J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995;14:4240-4248.
13. INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000;20:1436-1447.
14. Yang J, Chang E, Cherry AM, et al. Human endothelial cell life extension by telomerase expression. J Biol Chem 1999;274:26141-26148.
15. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/C DK4. Nature 1993;366:704-707.
16. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 1996;93:13742-13747.
17. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin 2007;57:43-66.
18. Choo CK, Ling MT, Chan KW, et al. Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate 1999;40:150-158.
19. Schwab TS, Stewart T, Lehr J, Pienta KJ, Rhim JS, Macoska JA. Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell cultures. Prostate 2000;44:164-171.
20. Gil J, Kerai P, Lleonart M, et al. Immortalization of primary human prostate epithelial cells by c-Myc. Cancer Res 2005;65:2179-2185.
21. Hande MP, Azizova TV, Geard CR, et al. Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome. Am J Hum Genet 2003;72:1162-1170.
22. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998;396:84-88.
23. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826.
24. Piao CQ, Liu L, Zhao YL, Balajee AS, Suzuki M, Hei TK. Immortalization of human small airway epithelial cells by ectopic expression of telomerase. Carcinogenesis 2005;26:725-731.
25. Henderson C, Mizzau M, Paroni G, Maestro R, Schneider C, Brancolini C. Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem 2003;278:12579-12589.
26. Blagosklonny MV, Robey R, Sackett DL, et al. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. Mol Cancer Ther 2002;1:937-941.
27. Caldarera E, Crooks NH, Muir GH, Pavone-Macaluso M, Carmichael PL. An appraisal of telomerase activity in benign prostatic hyperplasia. Prostate 2000;45:267-270.
28. Morales CP, Holt SE, Ouellette M, et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet 1999;21:115-118.
29. Palapattu GS, Sutcliffe S, Bastian PJ, et al. Prostate carcinogenesis and inflammation: Emerging insights. Carcinogenesis 2005;26:1170-1181.
30. INK4A fusion protein to human diploid fibroblasts. FEBS Lett 1998;427:203-208.
31. MerloA, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-692.
32. Gonzalez MV, Pello MF, Lopez-Larrea C, Suarez C, Menendez MJ, Coto E. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck. Clin Cancer Res 1995;1:1043-1049.
33. Artandi SE, Attardi LD. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem Biophys Res Commun 2005;331:881-890.
34. Shay JW. Toward identifying a cellular determinant of telomerase repression. J Natl Cancer Inst 1999;91:4-6.
35. Bright RK, Vocke CD, Emmert-Buck MR, et al. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 1997;57:995-1002.
36. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-1929.
37. Beausejour CM, Krtolica A, Galimi F, etal. Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J 2003;22:4212-4222.
38. Harada H, Nakagawa H, Oyama K, et al. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res 2003;1:729-738.
39. Jarrard DF, Sarkar S, Shi Y, et al. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res 1999;59:2957-2964.
40. Farwell DG, Shera KA, Koop JI, et al. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am J Pathol 2000;156:1537-1547.
41. Veitonmaki N, Fuxe J, Hultdin M, Roos G, Pettersson RF, Cao Y. Immortalization of bovine capillary endothelial cells by hTERT alone involves inactivation of endogenous p16INK4A/pRb. FASEB J 2003;17:764-766.
42. Piao CQ, Liu L, Zhao YL, Balajee AS, Suzuki M, Hei TK. Immortalization of human small airway epithelial cells by ectopic expression of telomerase. Carcinogenesis 2005;26:725-731.
43. Jarrard DF, Modder J, Fadden P, et al. Alterations in the p16/pRb cell cycle checkpoint occur commonly in primary and metastatic human prostate cancer. Cancer Lett 2002;185:191-199.